Helus Pharma Inc. SEC filings HELP
Helus Pharma Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 20, 2020. Its latest annual report, Form 40-F, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 1, 2026 | — |
| FWP | Free writing prospectus | Jun 24, 2026 | — |
| F-X | Form f-x | Dec 19, 2025 | — |
| F-10 | Form f-10 | Dec 19, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| FWP | Free writing prospectus | Oct 28, 2025 | — |
| F-10/A | Form f-10/a | Sep 17, 2025 | — |
| F-X | Form f-x | Jul 31, 2025 | — |
| F-10 | Form f-10 | Jul 31, 2025 | — |
| F-X | Form f-x | Jan 8, 2025 | — |
| F-10 | Form f-10 | Jan 8, 2025 | — |
| F-10POS | Form f-10pos | Apr 11, 2024 | — |
| F-X | Form f-x | Dec 29, 2023 | — |
| F-10 | Form f-10 | Dec 29, 2023 | — |
| F-10/A | Form f-10/a | Aug 17, 2023 | — |
| F-X | Form f-x | Jun 16, 2023 | — |
| F-10 | Form f-10 | Jun 16, 2023 | — |
| F-X | Filing | Oct 4, 2021 | — |
| F-10 | Filing | Oct 1, 2021 | — |
| F-X | Filing | Jul 27, 2021 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HELP (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Toronto
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833141
- Former names
- CYBIN INC. (until Sep 23, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.